EAA-090

Known as: EAA 090, Perzinfotel 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1998-2011
01219982011

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
OBJECTIVE To investigate the ability of perzinfotel (an N-methyl-d-aspartate receptor antagonist) and a proprietary phospholipase… (More)
Is this relevant?
2011
2011
GluN receptors are heteromers of obligatory GluN1 subunits and GluN2(A-D) subunits. In the present study, we addressed the… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
Is this relevant?
2010
2010
OBJECTIVE To determine the anesthetic-sparing effects of perzinfotel when administered as a preanesthetic via IV, IM, or SC… (More)
Is this relevant?
2009
2009
Previous studies with perzinfotel (1), a potent, selective, competitive NMDA receptor antagonist, showed it to be efficacious in… (More)
Is this relevant?
2009
2009
OBJECTIVE-To determine the effects of IV administration of perzinfotel and a perzinfotel-fentanyl combination on the minimum… (More)
  • table 1
  • table 2
Is this relevant?
2007
2007
OBJECTIVE To determine the effect of IV administration of perzinfotel on the minimum alveolar concentration (MAC) of isoflurane… (More)
Is this relevant?
2005
2005
Perzinfotel [EAA-090; [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)-ethyl]phosphonic acid] is a selective, competitive N… (More)
Is this relevant?
2005
2005
Perfusion of acute hippocampal slices with stimulatory buffers has long been known to induce rhythmic, large amplitude… (More)
Is this relevant?
2004
2004
Two novel N-methyl-d-aspartate (NMDA) antagonists with unique chemical structures, EAA-090 (2-[8,9-dioxo-2, 6-diazabicyclo[5.2.0… (More)
Is this relevant?
1998
1998
The diazabicyclic amino acid phosphonate 15, [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)ethyl]phosphonic acid, was… (More)
Is this relevant?